Abstract
Pulmonary epithelioid hemangioendothelioma (PEH), previously known as "intravascular bronchoalveolar tumor," is a rare vascular malignancy with an unpredictable prognosis. Treatment can vary from observation in asymptomatic patients to surgery in patients with resectable disease or chemotherapy in patients with disseminated disease. This report describes the clinical, radiological and pathological features of three cases of PEH and a review of the current literature.
MeSH terms
-
Antibiotics, Antineoplastic / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Biopsy
-
Doxorubicin / therapeutic use
-
Fatal Outcome
-
Female
-
Follow-Up Studies
-
Hemangioendothelioma, Epithelioid / diagnostic imaging*
-
Hemangioendothelioma, Epithelioid / drug therapy
-
Hemangioendothelioma, Epithelioid / pathology*
-
Humans
-
Interferons / therapeutic use
-
Lung / diagnostic imaging
-
Lung / ultrastructure
-
Lung Neoplasms / diagnostic imaging*
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / pathology*
-
Male
-
Middle Aged
-
Tomography, X-Ray Computed
Substances
-
Antibiotics, Antineoplastic
-
Antineoplastic Agents
-
Doxorubicin
-
Interferons